This company has been marked as potentially delisted and may not be actively trading. NASDAQ:CANB Can B (CANB) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisCompetitorsEarningsHeadlinesTrendsBuy This Stock About Can B Stock (NASDAQ:CANB) 30 days 90 days 365 days Advanced Chart Get Can B alerts:Sign Up Key Stats Today's Range$0.03▼$0.0350-Day Range$0.37▼$8.2452-Week Range$0.27▼$1.05Volume118,005 shsAverage Volume189,959 shsMarket Capitalization$2.30 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewCan B Corp. engages in the development, production, and sale of products and delivery devices containing cannabidiol. Its product portfolio includes hemp extract oils and sprays, pain and skin care, softgels and capsules, superfoods, supplements, bath and spa, and pets. The company was founded by Rolv Eitrem Heggenhougen and Romuald Stone on October 11, 2005 and is headquartered in Hicksville, NY.Read More… Receive CANB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Can B and its competitors with MarketBeat's FREE daily newsletter. Email Address CANB Stock News HeadlinesWhat Can Musk’s Department of Government Efficiency Actually Do?November 14, 2024 | msn.comYou're a true puzzle champion if you can decode this challenging maths riddle in 20 secondsNovember 13, 2024 | msn.comSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.May 19, 2025 | Stansberry Research (Ad)Pet Owner Shares Her WFH Set-Up—and Internet Can't Cope With the CutenessNovember 13, 2024 | msn.comTexans set franchise record with 5 interceptions but can’t hold on in 26-23 loss to LionsNovember 11, 2024 | apnews.comChina's H-20 Stealth Bomber Can Be Explained in 2 WordsNovember 11, 2024 | msn.comAnalysis: Ryan Blaney can join rarified air with consecutive championshipNovember 10, 2024 | msn.comHow Can Jr. A Hockey Leagues Benefit From The New NCAA Rule? Get YoungerNovember 10, 2024 | msn.comSee More Headlines CANB Stock Analysis - Frequently Asked Questions When did Can B IPO? Can B (CANB) raised $10 million in an initial public offering (IPO) on Tuesday, August 9th 2022. The company issued 2,000,000 shares at $5.05 per share. H.C. Wainwright & Co. acted as the underwriter for the IPO. What other stocks do shareholders of Can B own? Based on aggregate information from My MarketBeat watchlists, some other companies that Can B investors own include Fulcrum Therapeutics (FULC), Actinium Pharmaceuticals (ATNM), Provention Bio (PRVB), VIVUS (VVUS), Chimerix (CMRX), OpGen (OPGN) and Processa Pharmaceuticals (PCSA). Company Calendar Today5/19/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Drugs, proprietaries, & sundries Sub-IndustryN/A Current SymbolNASDAQ:CANB CIK1509957 Webwww.canbiola.com Phone(516) 595-9544FaxN/AEmployees16Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-9,740,000.00 Net Margins-1,238.33% Pretax Margin-1,351.68% Return on EquityN/A Return on Assets-218.65% Debt Debt-to-Equity RatioN/A Current Ratio0.14 Quick Ratio0.12 Sales & Book Value Annual Sales$2.16 million Price / Sales1.07 Cash FlowN/A Price / Cash FlowN/A Book Value($0.28) per share Price / Book-0.10Miscellaneous Outstanding Shares83,670,000Free Float74,137,000Market Cap$2.30 million OptionableNot Optionable Beta1.46 20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free Report This page (NASDAQ:CANB) was last updated on 5/19/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Can B Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Can B With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
